A California-based company has completed its first cervical procedure using personalised spine surgery devices.
Carlsmed’s Aprevo devices are tailored to the specific anatomical and alignment needs of each patient and are operated by an AI-powered surgical planning platform and digital manufacturing system.
The implantable devices and software platforms have FDA clearance for lumbar spine fusion, including anterior, lateral and transforaminal approaches.
With a wealth of experience using Aprevo for lumbar spine fusion procedures, Dr Joseph Osorio, chief of spine surgery at UC San Diego Health, performed this latest procedure in July.
He said: ‘Leveraging the Aprevo system for cervical fusion surgery allows a level of alignment which I believe is not achievable with traditional implants. The ability to customise each device to the patient’s unique pathology and anatomy signifies a significant advancement for my practice.’
Carlsmed anticipates a US launch for Aprevo in 2026 for cervical application.
This represents the latest positive milestone for the company, which went public recently.
Mike Cordonnier, chair and CEO of Carlsmed, said: ‘On the heels of our IPO, this first cervical procedure marks an exciting step as we expand our personalised surgical solutions to the cervical spine. We are proud to collaborate with Dr Osorio and UCSD Health to introduce this ground-breaking technology to patients. Our aim is to reduce revision surgeries, improve outcomes, and deliver better value across healthcare as we strive to set a new standard of care.’
